PA007515.m2a: In Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody (Clone: G6-31), Mouse IgG2a Kappa
The in vivo grade recombinant anti-mouse VEGF mouse IgG2a kappa monoclonal antibody was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: G6-31) specifically binds to mouse VEGF.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse VEGF protein.PA007514.m2a: In Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody (Clone: G6-23), Mouse IgG2a Kappa
The in vivo grade recombinant anti-mouse VEGF mouse IgG2a kappa monoclonal antibody was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: G6-23) specifically binds to mouse VEGF.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse VEGF protein.PA007513.m2a: In Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody (Clone: B20-4.1.1.1), Mouse IgG2a Kappa
The in vivo grade recombinant anti-mouse VEGF mouse IgG2a kappa monoclonal antibody was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: B20-4.1.1.1) specifically binds to mouse VEGF.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse VEGF protein.PA008019.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-L1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 10F.9G2.1 / G6-23)
The in vivo grade recombinant anti-mouse PD-L1 / VEGF-A bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.PA008022.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-L1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 10F.9G2.1 / G6-31)
The in vivo grade recombinant anti-mouse PD-L1 / VEGF-A bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.PA008016.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-L1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 10F.9G2.1 / B20-4.1.1.1)
The in vivo grade recombinant anti-mouse PD-L1 / VEGF-A bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.BP005758: Human EGF Protein with No Tag
Source: The recombinant Human EGF Protein, (amino acids Asn971-Arg1023) fused with No Tag, was produced in E.coli cells.
Activity: Immobilized recombinant Human EGF, No Tag at 2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human EGFR, hFc tag with the EC50 of 0.82 ug/ml determined by ELISA (QC Test). The affinity constant of 0.18 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004010: Human EGF Protein with the N-hFc Tag
Source: The recombinant Human EGF Protein, (amino acids Asn971-Arg1023) fused with a hFc tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human EGFR protein with the N-hFc tag at 1 ug/ml (100 ul/well) on the streptavidin precoated plate(5 ug/ml). Dose response curve for the recombinant Human EGF protein with the N-hFc tag with the EC50 of 5.5 ng/ml determined by ELISA. The affinity constant of 0.39 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003273: Canine EGF-Protein with the N-His Tag
Source: The recombinant Canine EGF-Protein, (amino acids Asn973-Arg1024) fused with a His tag at the N-terminus, was produced in E.coli cells.
Activity: Immobilized recombinant Canine EGF protein with the N-His tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human EGFR protein with the N-hFc tag with the EC50 of 4.7 ng/ml determined by ELISA (QC Test).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.C125P: Faricimab Biosimilar, Human ANGPT2/VEGFA Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade faricimab biosimilar specifically binds to the ANGPT2/VEGFA protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by faricimab.BP004023: Mouse EGF Protein with the N-hFc Tag
Source: The recombinant Mouse EGF Protein, (amino acids Asn977-Arg1029) fused with a hFc tag at the N-terminus, was produced in HEK 293 cells.
Activity: The affinity constant of 9.96 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.